Effectiveness of Treatments for Severe Sepsis
نویسندگان
چکیده
Critical Care Center, Hospital de Sabadell, CIBER Enfermedades Respiratorias, and Epidemiology and Assessment Unit, Instituto Universitario Fundación Parc Taulı́, Universidad Autónoma de Barcelona, Sabadell, Spain; Servicio de Medicina Intensiva, Hospital Infanta Leonor, Madrid, Spain; Medical ICU, Rhode Island Hospital, Brown University School of Medicine, Providence, Rhode Island; Servicio de Medicina Intensiva, Hospital Virgen de la Macarena, Sevilla; Servicio de Medicina Intensiva, Hospital Universitari de Bellvitge, Hospitalet de Llobregat; and Servicio de Medicina Intensiva, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain
منابع مشابه
بررسی سیتوکینهایTh1-Th2 در سطح سلولی در بیماران مبتلا به سپسیس و سپسیس شدید
Background: Sepsis is the leading cause of death in critically ill patients throughout the world. The incidence is increasing despite the major advances in the development of antimicrobial agents and other supportive treatments. Based on multiple studies, it has been shown that patient outcome depends on Th1 and Th2 cytokine response. Moreover, whenever the Th2 response is predominant, the seps...
متن کاملThe Prognostic Role of Mean Platelet Volume (MPV) in Sever Sepsis: is it True?
Background: The purpose of the present study was to examine the role of mean platelet volume (MPV) in comparison with Sequential Organ Failure Assessment (SOFA), quick SOFA (qSOFA), and Mortality in Severe Sepsis in the Emergency Department (MISSED) scoring systems in predicting hospital mortality among patients with severe sepsis. Methods: This follow-up stud...
متن کاملEconomic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis in Iran: Cost-Effectiveness Analysis
The aim of this study is to assess cost-effectiveness of infliximab, compared with conventional treatments in patients with moderate to severe Ulcerative Colitis (UC) in Iran. We developed an analytical decision model with a 5-year-time horizon to follow up 1000 hypothetical patients, in order to estimate treatment costs and outcomes. Hypothetical patients, were individuals with moderate to sev...
متن کاملEvaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.
OBJECTIVES The aim of this study was to assess the cost-effectiveness of drotrecogin alfa (activated) compared with best supportive care in a UK cohort of adult intensive-care patients with severe sepsis. METHODS A systematic review of evidence on the clinical- and cost-effectiveness of drotrecogin alfa (activated) was undertaken, and a decision-analytic model was developed to estimate the co...
متن کاملAn economic evaluation of activated protein C treatment for severe sepsis.
BACKGROUND Recombinant human activated protein C was shown in the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study to reduce mortality among patients with severe sepsis. A post hoc reanalysis by the Food and Drug Administration (FDA) of data from this study suggested that the reduction in mortality was restricted to patients with Acute Physiology and C...
متن کاملPrognostic Validity of Red Cell Distribution Width in Neonatal Sepsis
Background Neonatal sepsis is one of the most critical illness in neonates that is responsible for a great proportion of morbidity and mortality in neonates so early diagnosis and identification of high risk cases is a challenging aim of our study. The purpose of this study was to investigate the prognostic value of red cell distribution width (RDW), in neonatal sepsis at the time of admission ...
متن کامل